Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
Canadian Journal of Physiology and Pharmacology|October 1, 1985
N-Glucosidation of amobarbital in the catG Carro-Ciampi, M Jurima, D Kadar, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
A method for studying drug metabolism in populations: racial differences in amobarbital metabolismW Kalow, B K Tang, D Kadar, et al.
Biochemical Pharmacology|June 1, 1997
Interactions of amphetamine analogs with human liver CYP2D6D Wu, S V Otton, T Inaba, et al.
Advances in Clinical Chemistry|January 1, 1981
The plasma cholinesteerases: a new perspectiveS S Brown, W Kalow, W Pilz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Oxazepam as a probe of hepatic metabolism in patients with Alzheimer's diseaseM Fisman, T Inaba, W Kalow, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibitionM Schadel, D Wu, S V Otton, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1984
A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenaseT Inaba, M Nakano, S V Otton, et al.
European Journal of Clinical Pharmacology|October 16, 2001
Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamineS K Sy, B K Tang, A Pastrakuljic, et al.
Canadian Anaesthetists' Society Journal|July 1, 1973
Malignant hyperthermia: an investigation of five patientsB A Britt, W Kalow, A Gordon, et al.
Pharmacology & Toxicology|July 1, 1990
Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistryR F Tyndale, F J Gonzalez, J P Hardwick, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Canadian Journal of Physiology and Pharmacology|October 1, 1985
N-Glucosidation of amobarbital in the catG Carro-Ciampi, M Jurima, D Kadar, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
A method for studying drug metabolism in populations: racial differences in amobarbital metabolismW Kalow, B K Tang, D Kadar, et al.
Biochemical Pharmacology|June 1, 1997
Interactions of amphetamine analogs with human liver CYP2D6D Wu, S V Otton, T Inaba, et al.
Advances in Clinical Chemistry|January 1, 1981
The plasma cholinesteerases: a new perspectiveS S Brown, W Kalow, W Pilz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Oxazepam as a probe of hepatic metabolism in patients with Alzheimer's diseaseM Fisman, T Inaba, W Kalow, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibitionM Schadel, D Wu, S V Otton, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1984
A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenaseT Inaba, M Nakano, S V Otton, et al.
European Journal of Clinical Pharmacology|October 16, 2001
Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamineS K Sy, B K Tang, A Pastrakuljic, et al.
Canadian Anaesthetists' Society Journal|July 1, 1973
Malignant hyperthermia: an investigation of five patientsB A Britt, W Kalow, A Gordon, et al.
Pharmacology & Toxicology|July 1, 1990
Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistryR F Tyndale, F J Gonzalez, J P Hardwick, et al.
Pageof 19